Do you want to read an article? Please log in or register.
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Immune Response
Related content
Further Publications Immunology
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
Ann Rheum Dis
Moyon Q, Sterlin D, Miyara M, Anna F, Mathian A, Lhote R, Ghillani-Dalbin P, Breillat P, Mudumba S, de Alba S, Cohen-Aubart F, Haroche J, Pha M, Boutin THD, Chaieb H, Flores PM, Charneau P, Gorochov G, Amoura Z
doi: 10.1136/annrheumdis-2021-221097
Immune Response
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
NPJ Vaccines
Bos R, Rutten L, van der Lubbe JEM, Bakkers MJG, Hardenberg G, Wegmann F, Zuijdgeest D, de Wilde AH, Koornneef A, Verwilligen A, van Manen D, Kwaks T, Vogels R, Dalebout TJ, Myeni SK, Kikkert M, Snijder EJ, Li Z, Barouch DH, Vellinga J, Langedijk JPM, Zahn RC, Custers J, Schuitemaker H
doi: 10.1038/s41541-020-00243-x
Further Publications Dermatology
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Nature
Collier DA, Ferreira IATM, Kotagiri P, Datir R, Lim E, Touizer E, Meng B, Abdullahi A, CITIID-NIHR BioResource COVID-19 Collaboration., Elmer A, Kingston N, Graves B, Le Gresley E, Caputo D, Bergamaschi L, Smith KGC, Bradley JR, Ceron-Gutierrez L, Cortes-Acevedo P, Barcenas-Morales G, Linterman MA, McCoy L, Davis C, Thomson E, Lyons PA, McKinney E, Doffinger R, Wills M, Gupta RK
doi: 10.1038/s41586-021-03739-1
Further Publications Immunology
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
N Engl J Med
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J, COVE Study Group.
doi: 10.1056/NEJMoa2113017
Allergic DiseasesFurther Publications Immunology
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-analysis, GRADE Assessment, and International Consensus Approach
J Allergy Clin Immunol Pract
Greenhawt M, Abrams EM, Shaker M, Chu DK, Kahn D, Akin C, Alqurashi W, Arkwright P, Baldwin JL, Ben-Shoshan M, Bernstein J, Bingeman T, Blumchen K, Byrne A, Bognanni A, Campbell D, Campbell R, Chagla Z, Chan ES, Chan J, Comberiatti P, Dribin TE, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Grayson MH, Horner CC, Hourihane J, Katelaris CH, Kim H, Kelso JM, Lang D, Ledford D, Levin M, Lieberman J, Loh R, Mack D, Mazer B, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Oppenheimer J, Perrett KP, Ramsey A, Rank M, Robertson K, Shiek J, Spergel JM, Stukus D, Tang ML, Tracy JM, Turner PJ, Whalen-Browne A, Wallace D, Wang J, Wasserman S, Witty JK, Worm M, Vander Leek TK, Golden DB
doi: 10.1016/j.jaip.2021.06.006
Immune Response
Age-Related differences in immunological responses to SARS-CoV-2
J Allergy Clin Immunol Pract.
Yin Wong LS, Ling Loo EX, Hui Kang AY, Lau HX, Tambyah PA, Tham EH
doi: 10.1016/j.jaip.2020.08.026.
Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology
Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice
J Eur Acad Dermatol Venereol.
Gisondi P, Piaserico S, Conti A, Naldi L
doi: 10.1111/jdv.16515.
Further Publications Immunology
Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study
J Clin Immunol
Goudouris ES, Pinto-Mariz F, Mendonça LO, Aranda CS, Guimarães RR, Kokron C, Barros MT, Anísio F, Alonso MLO, Marcelino F, Valle SOR, Junior SD, Barreto IDP, Ferreira JFS, Roxo-Junior P, do Rego Silva AM, Campinhos FL, Bonfim C, Loth G, Fernandes JF, Garcia JL, Capelo A, Takano OA, Nadaf MIV, Toledo EC, Cunha LAO, Di Gesu RSW, Schidlowski L, Fillipo P, Bichuetti-Silva DC, Soldateli G, Ferraroni NR, de Oliveira Dantas E, Pestana S, Mansour E, Ulaf RG, Prando C, Condino-Neto A, Grumach AS
doi: 10.1007/s10875-021-01066-8
Further Publications Rheumatology
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Nat Med
Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, Flaxman A, Wright D, Bellamy D, Bittaye M, Dold C, Provine NM, Aboagye J, Fowler J, Silk SE, Alderson J, Aley PK, Angus B, Berrie E, Bibi S, Cicconi P, Clutterbuck EA, Chelysheva I, Folegatti PM, Fuskova M, Green CM, Jenkin D, Kerridge S, Lawrie A, Minassian AM, Moore M, Mujadidi Y, Plested E, Poulton I, Ramasamy MN, Robinson H, Song R, Snape MD, Tarrant R, Voysey M, Watson MEE, Douglas AD, Hill AVS, Gilbert SC, Pollard AJ, Lambe T, Oxford COVID Vaccine Trial Group.
doi: 10.1038/s41591-020-01194-5